Literature DB >> 14960025

Priming with testosterone enhances stimulated growth hormone secretion in boys with delayed puberty.

G Müller1, A Keller, A Reich, W Hoepffner, J Kratzsch, J M Buckler, W Kiess, E Keller.   

Abstract

BACKGROUND AND
OBJECTIVE: Tests for growth hormone (GH) deficiency are not always helpful in the differential diagnosis of physiological delay of growth and puberty and GH deficiency. PATIENTS AND METHODS: To enhance diagnostic specificity, we used a single dose testosterone priming before repeating the arginine stimulation test in 26 boys with short stature and only early signs of puberty who failed to show an adequate response of serum GH in the first test.
RESULTS: 77% (20/26 patients) increased their serum GH peak to more than 10 ng/ml, whereas six patients were still below this concentration.
CONCLUSION: We propose that testosterone priming is a useful tool to distinguish between physiological delay of growth and puberty and GH deficiency and should be included in the diagnostic procedure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14960025     DOI: 10.1515/jpem.2004.17.1.77

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  3 in total

1.  Needle-Free and Needle-Based Growth Hormone Therapy in Children: A Pooled Analysis of Three Long-Term Observational Studies.

Authors:  Tilman R Rohrer; Sabine Ceplis-Kastner; Norbert Jorch; Hermann L Müller; Roland Pfäffle; Thomas Reinehr; Annette Richter-Unruh; Claudia Weißenbacher; Paul-Martin Holterhus; Dr Sabine Clips-Kastner Ferring Arzneimittel GmbH
Journal:  Horm Res Paediatr       Date:  2019-03-05       Impact factor: 2.852

Review 2.  Growth Hormone Stimulation Testing: To Test or Not to Test? That Is One of the Questions.

Authors:  Mabel Yau; Robert Rapaport
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

Review 3.  Growth hormone deficiency and replacement in children.

Authors:  Margaret C S Boguszewski
Journal:  Rev Endocr Metab Disord       Date:  2020-10-08       Impact factor: 6.514

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.